In the Era of Cardiovascular–Kidney–Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and TherapyVincenzo Quagliariello, Nicola Maurea, Massimiliano Berretta et al.|Cancers|2025Cited by 25
Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer PatientsVincenzo Quagliariello, Nicola Maurea, Irma Bisceglia et al.|International Journal of Molecular Sciences|2024Cited by 18
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionalsIrma Bisceglia, Furio Colivicchi, Maria Laura Canale et al.|Frontiers in Cardiovascular Medicine|2023Cited by 17
Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncologyVincenzo Quagliariello, Nicola Maurea, Margherita Passariello et al.|Frontiers in Cardiovascular Medicine|2024Cited by 16
Women at heart: Introducing gender cardio-oncologyMaria Laura Canale, Furio Colivicchi, Irma Bisceglia et al.|Frontiers in Cardiovascular Medicine|2022Cited by 14